The dual inhibitor of GLS and GDH, CPD‐3B (Hexylselen) has demonstrated to effectively disrupt mitochondrial membrane potential and to induce apoptosis of glutamine addicted cancer cells without showing toxicity to normal cells [113]. The gene discussed is GLUD1; the disease is cancer.